Adaptimmune Therapeutics (ADAP) null Earnings

9MayConfirmed
Aug 21
Nov 21
Mar 22
May 22
-0.3
-0.15
-0.01
0.14

Details

Expected EPS
-0.22
Actual EPS
-0.3
Surprise EPS
-0.08
Surprise Percent
+36.36%

Description

Adaptimmune Therapeutics (ADAP) has reported earnings of -0.3 per share for .

0 Comments

Share your thoughts